EVOKE PHARMA INC

NASDAQ: EVOK (Evoke Pharma, Inc.)

Last update: 2 days ago, 7:43PM

4.76

0.01 (0.21%)

Previous Close 4.75
Open 4.75
Volume 5,044
Avg. Volume (3M) 174,439
Market Cap 7,418,294
52 Weeks Range
1.94 (-59%) — 12.32 (158%)
Earnings Date 11 Aug 2025 - 15 Aug 2025
Profit Margin -43.80%
Operating Margin (TTM) -42.26%
Diluted EPS (TTM) -1.23
Quarterly Revenue Growth (YOY) 77.50%
Total Debt/Equity (MRQ) 88.08%
Current Ratio (MRQ) 1.55
Operating Cash Flow (TTM) -3.88 M
Levered Free Cash Flow (TTM) -2.26 M
Return on Assets (TTM) -21.70%
Return on Equity (TTM) -108.77%

AIStockmoo Score

0.4
Weak profitability. Negative cash flow. info
From our AI Insight report's view of expected return against risk. info NA
Relative Valuation info NA
Implied Growth info NA
Valuation History info NA
Return on Capital info NA
Holdings' Value info NA
Risk Premium info NA
Market Valuation info NA
Uptrend over the past year. Trading near its 52-week high. info
Near its medium-term trend line. info
From our AI technical analysis of the chart. info NA
Technical Setup info NA
Candle Patterns info NA
No recent price targets, so based on how targets have been revised. info
Holdings' Sentiment info NA
News Mood info NA
Insider Activity info NA
Institutional Flow info NA
Short Interest info NA
Market environment cautious. info
Sector outperforming the market.
The pillars disagree, so the score is softened.
Earnings per share have risen every year. Made a loss in recent years. info
Price is near its 52-week average. Down over 5 years. info
No clear trend across the short, medium and long term. info
Price is near support. info
Final Score 0.37
Show all

Market Trend

Short Term Medium Term
Industry Drug Manufacturers - Specialty & Generic (US) Mixed Mixed
Drug Manufacturers - Specialty & Generic (Global) Mixed Mixed
Stock Evoke Pharma, Inc. - -

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B Score
EVOK 7 M - - - 0.4
SUPN 6 B 27.84% - 1.59 -1.0
ANIP 2 B - 13.74 2.57 -0.1
COLL 783 M - 23.13 2.72 0.1
TKNO 480 M - - - 0.8
AQST 435 M - - - -1.7

Select this tab to load the latest available analysis.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Investment Style Small Value
% Held by Insiders 1.34%
% Held by Institutions 16.23%

No data within this time range.

No data within this time range.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

Risk / Reward
TP1:
TP2:

Loss to SL against profit to each target, from EP. A ratio of 2 or more is usually sought.

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria